Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bob Martin is a prominent UK-based pet healthcare company that specializes in the manufacture and distribution of over-the-counter parasite control and wellness products. Established in 1892, the company provides a comprehensive range of flea and tick treatments, dewormers, and nutritional supplements for cats, dogs, and other small animals. The brand is widely recognized for its Bob Martin Clear range, which utilizes active ingredients like fipronil to manage infestations. In 2019, the company's assets and brand were acquired by Pets Choice, ensuring the continued availability of its products in major retail and grocery channels. Bob Martin remains a household name in the European pet care market, focusing on affordable and effective home-use healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bob Martin.